The pharmaceutical giant has hailed strong first-quarter results, with group sales of £9.8bn, up 32% on the year, setting the company on track to launch its consumer healthcare arm, Haleon, in July.
GSK reports strong first-quarter results
Share
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.